Johns Hopkins Medical Center

Baltimore, Maryland 21287

2 studies enrolling now · 36 studies all time

What they study most

ALL, AML, Acute Ischemic Stroke, Acute Leukemia of Ambiguous Lineage, Acute Pancreatitis, Anaplastic Astrocytoma, Atherosclerotic Cardiovascular Disease, Benign Prostatic Hyperplasia, Bipolar Disorder, Bladder Cancer, Bone Cancer, Carcinoma

Studies at this site

• Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke — Recruiting now
• uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto — Recruiting now
• Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer — Running, not enrolling
• Women's Heart Attack Research Program: Stress Ancillary Study — Completed
• Heart Attack Research Program- Imaging Study — Running, not enrolling
• A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) — Stopped early
• Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening — Running, not enrolling
• APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS) — Completed
• A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer — Stopped early
• Osteosarcoma Maintenance Therapy With OST31-164 — Running, not enrolling
• A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer — Completed
• Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) — Completed
• Immune Modulators for Treating COVID-19 — Completed
• Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia — Stopped early
• Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term — Completed
• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant — Completed
• Analyses of Human Samples Collected in Clinical Trials — Completed
• Patient-reported Outcome Scale in Acute Pancreatitis — Completed
• Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse — Completed
• POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients — Completed
• Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose — Completed
• Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) — Stopped early
• Early Diagnosis of Pulmonary Nodules — Completed
• Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis — Completed
• Neurostimulation for the Treatment of Post-Operative Ileus — Withdrawn before enrolling
• Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration — Completed
• Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery — Completed
• Efficacy of YKP3089 in Patients With Photosensitive Epilepsy — Completed
• ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients — Withdrawn before enrolling
• RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness — Completed
• Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents — Completed
• A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer — Completed
• Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee — Completed
• 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma — Status unconfirmed
• Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme — Withdrawn before enrolling